Statement of Organization, Functions and Delegations of Authority, 46098-46099 [2012-18897]
Download as PDF
<![CDATA[
46098
Federal Register / Vol. 77, No. 149 / Thursday, August 2, 2012 / Notices
Email comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Dated: July 25, 2012.
Wendy Ponton,
Director, Office of Management.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization, Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at 77 FR 38071–38072
dated June 26, 2012).
This notice reflects organizational
changes to the Health Resources and
Services Administration. This notice
updates the functional statement for the
Healthcare Systems Bureau (RR) and the
Bureau of Primary Health Care (RC).
Specifically, this notice: (1) Transfers
the Division of National Hansen’s
Disease Program from the Bureau of
Primary Health Care (RC), to the
Healthcare Systems Bureau (RR); and (2)
updates the functional statement for the
Office of the Associate Administrator
Healthcare Systems Bureau (RR).
mstockstill on DSK4VPTVN1PROD with NOTICES
Chapter RR—Healthcare Systems
Bureau
Section RR–10, Organization
Delete in its entirety and replace with
the following:
The Healthcare Systems Bureau (RR)
is headed by the Associate
Administrator, who reports directly to
the Administrator, Health Resources
and Services Administration. The
Healthcare Systems Bureau includes the
following components:
(1) Office of the Associate
Administrator (RR);
(2) Division of Transplantation (RR1);
(3) Division of Vaccine Injury
Compensation (RR4);
(4) Office of Pharmacy Affairs (RR7);
(5) Division of Poison Control and
Healthcare Facilities (RR9); and
(6) Division of National Hansen’s
Disease Program (RRH).
18:15 Aug 01, 2012
(1) Delete the functional statement for
the Office of the Associate
Administrator (RR) and replace in its
entirety; and (2) add the functional
statement for the Division of National
Hansen’s Disease Program (RRH).
Office of the Associate Administrator
(RR)
[FR Doc. 2012–18945 Filed 8–1–12; 8:45 am]
VerDate Mar<15>2010
Section RR–20, Functions
Jkt 226001
The Healthcare Systems Bureau leads
the Agency in providing health care
programs to eligible organizations
around the country. Specifically, (1)
Administers the Organ Transplantation
Program to include the Organ
Procurement and Transplantation
Network to facilitate the allocation of
donor organs to patients waiting for an
organ transplant and the Scientific
Registry of Transplant Recipients that
provides analytic support to the Organ
Procurement and Transplantation
Network in the development and
assessment of organ allocation and other
Organ Procurement and Transplantation
Network policies; (2) administers the
C.W. Bill Young Cell Transplantation
Program to increase the number of
unrelated blood stem cell transplants
and improve the outcomes of blood
stem cell transplants; (3) administers the
National Cord Blood Inventory to
increase the number of high quality cord
blood units available for
transplantation; (4) develops and
maintains a national program of grants
and contracts to organ procurement
organizations and other entities to
increase the number of organs made
available for transplantation; (5)
manages the national program for
compliance with the Hill-Burton
uncompensated care requirement and
other assurances; (6) directs and
administers a congressionally-directed
grant program for the construction/
renovation/equipping of health care and
other facilities; (7) directs and
administers the National Vaccine Injury
Compensation Program; (8) manages
and promotes the 340B Drug Pricing
Program; (9) directs and administers the
Poison Center Support, Enhancement,
and Awareness Act; (10) implements
and administers the Countermeasures
Injury Compensation Program under
PREP Act authorities; and (11) manages
the National Hansen’s Disease Programs
in accordance with regulations of the
Public Health Service.
Division of National Hansen’s Disease
Program (RRH)
Manages the National Hansen’s
Disease Program in accordance with
regulations of the Public Health Service.
Specifically: (1) Provides care and
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
treatment for persons with Hansen’s
disease, including managing a national
outpatient health care delivery program;
(2) conducts research and provides
education and training on Hansen’s
disease; and (3) provides consultation to
and coordinates activities within HRSA
and HHS, and with other Federal
agencies, State and local governments,
and other public and private
organizations involved in Hansen’s
disease activities.
Chapter RC—Bureau of Primary Health
Care
Section RC–10, Organization
(1) Delete in its entirety and replace
with the following:
The Bureau of Primary Health Care
(RC) is headed by the Associate
Administrator, who reports directly to
the Administrator, Health Resources
and Services Administration. The
Bureau of Primary Health Care includes
the following components:
(1) Office of the Associate
Administrator (RC);
(2) Office of Administrative
Management (RCM);
(3) Office of Training and Technical
Assistance Coordination (RCS);
(4) Office of Policy and Program
Development (RCH);
(5) Office of Quality and Data (RCK);
(6) Office of Special Population
Health (RCG);
(7) Northeast Division (RCU);
(8) Central Southeast Division (RCV);
(9) North Central Division (RCT); and
(10) Southwest Division (RCW).
Section RC–20, Functions
(1) Delete the functional statement for
the Office of the Associate
Administrator (RC) and replace in its
entirety.
Office of the Associate Administrator
(RC)
Provides overall leadership, direction,
coordination, and planning in support
of BPHC programs. Specifically: (1)
Establishes program goals, objectives
and priorities, provides oversight to
their execution; (2) plans, directs,
coordinates and evaluates BPHC-wide
management activities; and (3)
maintains effective relationships within
HRSA and with other Department of
Health and Human Services (HHS)
organizations, other Federal agencies,
state and local governments, and other
public and private organizations
concerned with primary health care,
eliminating health disparities, and
improving the health status of the
Nation’s underserved and vulnerable
populations.
E:\FR\FM\02AUN1.SGM
02AUN1
Federal Register / Vol. 77, No. 149 / Thursday, August 2, 2012 / Notices
Section RC–30, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
Dated: July 16, 2012.
Mary K. Wakefield,
Administrator.
[FR Doc. 2012–18897 Filed 8–1–12; 8:45 am]
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: July 27, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–18877 Filed 8–1–12; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Clinical Center; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as amended
because the premature disclosure of
other and the discussions would likely
to significantly frustrate implementation
of recommendations.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: October 1, 2012.
Open: 10 a.m. to 1:15 p.m.
Agenda: Discussion of intramural clinical
research operational and funding issues.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Closed: 1:15 p.m. to 2 p.m.
Agenda: To discuss personnel matters.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Contact Person: Maureen E. Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, (301) 496–2897.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
VerDate Mar<15>2010
18:15 Aug 01, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project: Immune Regulation by
Cannabinoids.
Date: September 5–6, 2012.
Time: 7 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
46099
Dated: July 27, 2012.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–18876 Filed 8–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: August 27, 2012.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Maja Maric, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
DHHS/NIH/NIAID, 6700B Rockledge Drive,
Room 3266, Bethesda, MD 20892–7616, 301–
451–2634, maja.maric@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: August 28, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
6700B Rockledge Drive, MSC–7616, Room
3119, Bethesda, MD 20892–7616, 301–496–
7042, sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 77, Number 149 (Thursday, August 2, 2012)]
[Notices]
[Pages 46098-46099]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18897]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Statement of Organization, Functions and Delegations of Authority
This notice amends Part R of the Statement of Organization,
Functions and Delegations of Authority of the Department of Health and
Human Services (HHS), Health Resources and Services Administration
(HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 77
FR 38071-38072 dated June 26, 2012).
This notice reflects organizational changes to the Health Resources
and Services Administration. This notice updates the functional
statement for the Healthcare Systems Bureau (RR) and the Bureau of
Primary Health Care (RC). Specifically, this notice: (1) Transfers the
Division of National Hansen's Disease Program from the Bureau of
Primary Health Care (RC), to the Healthcare Systems Bureau (RR); and
(2) updates the functional statement for the Office of the Associate
Administrator Healthcare Systems Bureau (RR).
Chapter RR--Healthcare Systems Bureau
Section RR-10, Organization
Delete in its entirety and replace with the following:
The Healthcare Systems Bureau (RR) is headed by the Associate
Administrator, who reports directly to the Administrator, Health
Resources and Services Administration. The Healthcare Systems Bureau
includes the following components:
(1) Office of the Associate Administrator (RR);
(2) Division of Transplantation (RR1);
(3) Division of Vaccine Injury Compensation (RR4);
(4) Office of Pharmacy Affairs (RR7);
(5) Division of Poison Control and Healthcare Facilities (RR9); and
(6) Division of National Hansen's Disease Program (RRH).
Section RR-20, Functions
(1) Delete the functional statement for the Office of the Associate
Administrator (RR) and replace in its entirety; and (2) add the
functional statement for the Division of National Hansen's Disease
Program (RRH).
Office of the Associate Administrator (RR)
The Healthcare Systems Bureau leads the Agency in providing health
care programs to eligible organizations around the country.
Specifically, (1) Administers the Organ Transplantation Program to
include the Organ Procurement and Transplantation Network to facilitate
the allocation of donor organs to patients waiting for an organ
transplant and the Scientific Registry of Transplant Recipients that
provides analytic support to the Organ Procurement and Transplantation
Network in the development and assessment of organ allocation and other
Organ Procurement and Transplantation Network policies; (2) administers
the C.W. Bill Young Cell Transplantation Program to increase the number
of unrelated blood stem cell transplants and improve the outcomes of
blood stem cell transplants; (3) administers the National Cord Blood
Inventory to increase the number of high quality cord blood units
available for transplantation; (4) develops and maintains a national
program of grants and contracts to organ procurement organizations and
other entities to increase the number of organs made available for
transplantation; (5) manages the national program for compliance with
the Hill-Burton uncompensated care requirement and other assurances;
(6) directs and administers a congressionally-directed grant program
for the construction/renovation/equipping of health care and other
facilities; (7) directs and administers the National Vaccine Injury
Compensation Program; (8) manages and promotes the 340B Drug Pricing
Program; (9) directs and administers the Poison Center Support,
Enhancement, and Awareness Act; (10) implements and administers the
Countermeasures Injury Compensation Program under PREP Act authorities;
and (11) manages the National Hansen's Disease Programs in accordance
with regulations of the Public Health Service.
Division of National Hansen's Disease Program (RRH)
Manages the National Hansen's Disease Program in accordance with
regulations of the Public Health Service. Specifically: (1) Provides
care and treatment for persons with Hansen's disease, including
managing a national outpatient health care delivery program; (2)
conducts research and provides education and training on Hansen's
disease; and (3) provides consultation to and coordinates activities
within HRSA and HHS, and with other Federal agencies, State and local
governments, and other public and private organizations involved in
Hansen's disease activities.
Chapter RC--Bureau of Primary Health Care
Section RC-10, Organization
(1) Delete in its entirety and replace with the following:
The Bureau of Primary Health Care (RC) is headed by the Associate
Administrator, who reports directly to the Administrator, Health
Resources and Services Administration. The Bureau of Primary Health
Care includes the following components:
(1) Office of the Associate Administrator (RC);
(2) Office of Administrative Management (RCM);
(3) Office of Training and Technical Assistance Coordination (RCS);
(4) Office of Policy and Program Development (RCH);
(5) Office of Quality and Data (RCK);
(6) Office of Special Population Health (RCG);
(7) Northeast Division (RCU);
(8) Central Southeast Division (RCV);
(9) North Central Division (RCT); and
(10) Southwest Division (RCW).
Section RC-20, Functions
(1) Delete the functional statement for the Office of the Associate
Administrator (RC) and replace in its entirety.
Office of the Associate Administrator (RC)
Provides overall leadership, direction, coordination, and planning
in support of BPHC programs. Specifically: (1) Establishes program
goals, objectives and priorities, provides oversight to their
execution; (2) plans, directs, coordinates and evaluates BPHC-wide
management activities; and (3) maintains effective relationships within
HRSA and with other Department of Health and Human Services (HHS)
organizations, other Federal agencies, state and local governments, and
other public and private organizations concerned with primary health
care, eliminating health disparities, and improving the health status
of the Nation's underserved and vulnerable populations.
[[Page 46099]]
Section RC-30, Delegations of Authority
All delegations of authority and re-delegations of authority made
to HRSA officials that were in effect immediately prior to this
reorganization, and that are consistent with this reorganization, shall
continue in effect pending further re-delegation.
This reorganization is effective upon date of signature.
Dated: July 16, 2012.
Mary K. Wakefield,
Administrator.
[FR Doc. 2012-18897 Filed 8-1-12; 8:45 am]
BILLING CODE 4165-15-P
